The polycystic ovary syndrome (PCOS) is an endocrine metabolic disorder affecting 7% to 10% of women during reproductive age. The metabolic syndrome is understood as a set of clinical factors related to the potential increase in the risk of cardiovascular disease, type II diabetes mellitus, and early mortality. The hyperandrogenism and insulin resistance related to PCOS will result in increased cardiovascular risk and extending throughout the patient’s lifetime.
Citation: Neves EM, Fonseca AM, Bagnoli VR, Souza MA, AraÃºjo Moraes SDT, et al. (2014) Polycystic Ovary Syndrome: Correlation between Phenotypes and Metabolic Syndrome. J Steroids Hormon Sci 5:132. doi: 10.4172/2157-7536.1000132